AstraZeneca may be fined up to USD8 million by Shenzhen Customs' anti-smuggling bureau on suspicion of evading USD1.6 million import taxes for its Enhertu drug, the global pharmaceutical giant told Yicai today. AstraZeneca received the notice from the Chinese customs authority in January.